FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS
Germany
99928715.4
Filed on 1999-06-16
99928715.4
Filed on 1999-06-16
FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS
France
99928715.4
Filed on 1999-06-16
99928715.4
Filed on 1999-06-16
FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS
United Kingdom
99928715.4
Filed on 1999-06-16
99928715.4
Filed on 1999-06-16
Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors
Patent Cooperation Treaty
PCT/US2006/005888
Filed on 2006-02-16
PCT/US2006/005888
Filed on 2006-02-16
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanoma
New Zealand
524636
Filed on 2003-03-06
524636
Filed on 2003-03-06
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas
European Patent
01968307.7
Filed on 2001-08-31
01968307.7
Filed on 2001-08-31
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas
Australia
2001288562
Filed on 2001-08-31
2001288562
Filed on 2001-08-31
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanomas
Canada
2419567
Filed on 2001-08-31
2419567
Filed on 2001-08-31
INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING
US Application 11/299,122
Filed on 2005-12-09
Filed on 2005-12-09